John Rothman
23Patents
7h-index
11Co-inventors
66Inventor score
Filing activity: Mar 3, 1989 → Aug 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5047249A | Compositions and methods for treating skin conditions and promoting wound healing | Human Necessities | 114 | Expired |
| USD553544S1 | Motor vehicle | General | 56 | Expired |
| US8114414B2 | Compositions and methods for treatment of cervical cancer | Chemistry; Metallurgy | 22 | Active |
| US9549973B2 | Compositions and methods comprising KLK3 or FOLH1 antigen | Chemistry; Metallurgy | 16 | Active |
| US9463227B2 | Listeria-based adjuvants | Human Necessities | 16 | Active |
| US8956621B2 | Compositions and methods for treatment of cervical dysplasia | Chemistry; Metallurgy | 14 | Active |
| US9012141B2 | Compositions and methods comprising KLK3 of FOLH1 antigen | Chemistry; Metallurgy | 13 | Active |
| US10064898B2 | Listeria-based adjuvants | Emerging Cross-Sectional Technologies | 7 | Active |
| US11446369B2 | Compositions and methods comprising KLK3 or FOLH1 antigen | Chemistry; Metallurgy | 3 | Active |
| US10548876B2 | Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof | Human Necessities | 3 | Active |
| US9993460B2 | Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof | Human Necessities | 3 | Active |
| US10751313B2 | Compositions and methods for treating autism | Human Necessities | 2 | Active |
| US10905698B1 | Methods of treating SARS-COV-2 infections | Emerging Cross-Sectional Technologies | 2 | Active |
| US11633372B2 | Compositions and methods for treating autism | Human Necessities | 1 | Active |
| US10500192B2 | Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof | Human Necessities | 1 | Active |
| US9974774B2 | Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof | Human Necessities | 1 | Active |
| US10813901B2 | Compositions and methods for treating autism | Human Necessities | 1 | Active |
| US11931329B2 | Compositions and methods for treating anxiety-related disorders | Human Necessities | 0 | Active |
| US11147800B2 | Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof | Human Necessities | 0 | Active |
| US11446268B2 | Compositions and methods for treating anxiety-related disorders | Human Necessities | 0 | Active |
| US12150924B2 | Compositions and methods for treating autism | Human Necessities | 0 | Active |
| US11607418B2 | Methods of treating SARS-CoV-2 infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US11135201B2 | Compositions to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.